Bentley Pharma drug delivery news

BNT will separate its drug delivery and generics businesses. The drug delivery business will spin out into CPEX Pharmaceuticals Inc., which will trade on NASDAQ under the symbol CPEX. BNT shareholders will own the newco, which will develop technologies based on its CPE-215 permeation enhancement technology, which enhances drug absorption across a variety of biological membranes including the skin, mouth, nose and eye. BNT's drug delivery business segment had revenues of $4.8 million in 1H07 and $8.4 million in 2006. ...